Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero-Reference-Cited by-同舟云学术

Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero

Published:2012-11-21 Issue:1 Volume:54 Page:165-171
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:

Author:

Campbell Ellen,Devenney Emma,Morrow Jim,Russell Aline,Smithson William Henry,Parsons Linda,Robertson Iain,Irwin Beth,Morrison Patrick J.,Hunt Stephen,Craig John

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.12001/fullpdf

Reference17 articles.

1. Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations;Azzato;Pharmacogenet Genomics,2010

2. Final results from 18 years of the International Lamotrigine Pregnancy Registry;Cunnington;Neurology,2011

3. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene;Dean;Clin Genet,1999

4. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth;Dean;J Med Genet,2002

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy;JAMA Neurology;2024-05-01

2. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child;Cochrane Database of Systematic Reviews;2023-08-29

3. Birth outcomes in pregnant women with epilepsy: A Nationwide multicenter study from Türkiye;Epilepsia;2023-07-14

4. Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations;Advances in Therapy;2023-06-27

5. Current safety concerns about the use of antiseizure medications in pregnancy;Expert Opinion on Drug Safety;2022-12-02